Zurück zu den Rankings

AXA SA (AXAHF)

NEUTRAL
Financial ServicesInsurance - DiversifiedFrance

Fundamental

63

Kurs

$43.68

Marktkapitalisierung

$91.71B

Teil 1 · Was das Unternehmen wert ist

Übersicht

AXA insures homes, cars, businesses and people against loss, illness and death, and sells life-savings and health policies alongside its property and casualty business. It collects premiums from millions of policyholders across Europe, Asia and elsewhere, and its AXA XL unit specializes in large commercial and specialty risks. A much smaller asset management arm invests money for clients for a fee.

Wie das Geld verdient wird

Premiums are collected upfront and claims are paid later, sometimes decades later for life and health policies, so profit comes from underwriting discipline — pricing risk correctly — plus the investment income earned on the funds held in between. Asset management adds a smaller, fee-based income stream that depends on the value of assets managed rather than on claims experience.

Umsatz nach Segment

Property & Casualty50.3%

Insurance for cars, homes, businesses and large commercial and specialty risks, including through the AXA XL unit.

Life & Health49%

Savings, protection and health policies, with health premiums growing faster than the rest of the group in the latest year.

Asset Management0.8%

Fee-based investment management, now much smaller after the 2025 sale of AXA Investment Managers to BNP Paribas.

Wettbewerbsvorteil

Skaleneffekte · Schmal

A global brand, broad distribution and a large capital base give AXA underwriting and pricing advantages over smaller insurers. The advantage is not exclusive, however: several other large composite insurers operate at similar scale in AXA's core European and Asian markets, and policyholders can and do switch insurers at renewal.

Was die Nachfrage antreibt

Defensiv

Car, home and liability insurance are largely mandatory or near-mandatory, so premium volumes hold up through economic downturns better than most consumer businesses. Growth still responds to the economy at the margin, through new business formation, asset values for savings products, and how much coverage households choose to buy.

Wichtigste Risiken

  • Frequency and severity of insured losses — The company lists the frequency and severity of insured loss events, including weather-related catastrophes, as a main risk factor; it targets a normalized natural-catastrophe load of about 4.5 points of the combined ratio, and a worse year than that assumption directly hits underwriting profit.
  • Interest rate and market conditions — The company identifies market performance and exchange- and interest-rate fluctuations as a key risk, since they affect both the value of the investment portfolio backing its policies and the cost of long-term savings guarantees.
  • Mortality and morbidity assumptions — Life and health results depend on how actual mortality and morbidity compare with the assumptions used to price policies decades in advance; the company lists these levels among its principal risk factors.

Die Argumente dafür

Buyers argue that growth across both Property & Casualty and Life & Health in 2025, together with a still-comfortable Solvency II capital ratio, shows a diversified and well-capitalized insurer, and that the sale of the asset management arm sharpens the focus on the core, better-margin insurance business.

Die Argumente dagegen

Sellers fear that a normalized natural-catastrophe assumption of 4.5 points can be exceeded in a genuinely bad year for weather losses, that a large long-duration life book stays exposed to interest-rate swings for decades, and that the Solvency II capital ratio has already declined from year-end 2025 levels, leaving less buffer than before.

Written by the editors, published on 18. August 2026

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 23. August 2026 with claude-opus-5 — shared with all users

P/E: 10.6Score: 68Market cap: $195.01B

Europe's other large multiline insurer, competing with AXA for the same retail, health and corporate property-and-casualty customers in Germany, France, Italy and Asia.

Assicurazioni Generali S.p.A.G

Sells life, health and property-and-casualty policies through agent networks in the same Continental European markets where AXA earns most of its premiums, Italy and France above all.

Zurich Insurance Group AGZURN

Goes head-to-head with AXA XL for the global commercial property-and-casualty programmes of large corporations, and with AXA's retail arms in Switzerland, Germany and Italy.

Chubb LimitedCB

Writes the same large-corporate and specialty property-and-casualty risks that AXA XL underwrites, competing broker by broker for the same commercial accounts.

Covéa (MAAF, MMA, GMF)Not tracked

France's leading motor and home insurer, disputing with AXA France the same domestic retail policyholders that make France AXA's largest single market.

Aviva plcAV.

Competes with AXA's UK and Irish operations for the same general insurance, group health and commercial customers.

Bilanz & Liquidität

Umsatz

$96.20B

Letzte 12 Monate bis zum zuletzt gemeldeten Quartal — Schätzung aus Kennzahlen je Aktie

Nettogewinn

$10.17B

Letzte 12 Monate bis zum zuletzt gemeldeten Quartal — Schätzung aus Kennzahlen je Aktie

Freier Cashflow

$-26.39B

Gesamtes Eigenkapital

$46.19B

Gesamtverbindlichkeiten

$61.11B

Current Ratio

11.53

Zinsdeckungsgrad

-

Schulden/EBITDA

-

Gewinn je Aktie

Umsatz & Nettogewinn

Freier Cashflow

Ertragsaufschlüsselung

Historische Aufstellung

Margen im Zeitverlauf

Verschuldung im Zeitverlauf

Wie schwer die Schulden wiegen

Wachstumsraster

Wachstum — Umsatz

Innerer-Wert-Schätzung

Unterbewertet

Innerer Wert

$82.95

Aktueller Kurs

$43.68

Sicherheitsmarge

+47.3%

Innerer-Wert-Spanne

$53.92 - $111.98

Bewertungsmethoden

Analyst Target:$50.51
DCF:$132.71
PE-based:$37.13
Graham Growth:$190.99
EPV:$42.55
Analystenkonsens:Starker Kauf (25B / 3H / 0S)
Letzte Gewinnüberraschung:-2.91%

Bewertungskennzahlen

P/E-Verhältnis

9.07

ROE

14.9%

P/B-Verhältnis

2.00

P/FCF

-

Bruttomarge

14.9%

ROIC

8.5%

Rentabilitäts-Radar

Value Creation (Economic Moat)

ROIC

8.5%

WACC

5.9%

ROIC − WACC

+2.6 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Fundamentalanalyse-Kriterien

Bestanden (12)

  • Price CAGR 6.77%
  • ROIC 8.5%
  • P/B Ratio 2.00
  • Debt/Equity ratio
  • Operating Margin 11.6%
  • Current Ratio
  • Price below Graham Number
  • ROE 21.9%
  • Analyst Consensus 89% Buy
  • PEG Ratio 0.32
  • Earnings Quality (OCF/NI) 1.52
  • Net Margin Trend 10.7% vs 9.0%

Nicht bestanden (6)

  • Gross Margin 14.9%
  • Positive Free Cash Flow
  • DCF valuation (Unknown)
  • Revenue Growth 5Y -4.2%
  • Earnings Surprise avg -2.0%
  • Piotroski F-Score 2/9

Nicht verfügbar (9)

  • EPS data insufficient
  • P/FCF NaN
  • Dividend Payout NaN%
  • CapEx intensity
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Share Dilution (missing shares data)

Piotroski F-Score

2/9

Ernsthafte finanzielle Bedenken

score
criteria

Gewinnqualität

1.52

Hohe Qualität: Gewinne durch Cashflow gedeckt

Aktienverwässerung

-

Aktienrückkäufe. Aktionärsfreundlich

Unternehmensführung

Führungsteam

NamePositionAlter
Dr. Thomas Buberl Ph.D.CEO & Director52
Ms. Helen BrowneGroup General Counsel & Employee Shareholders Representative Director63
Mr. Alban de Mailly NesleGroup Chief Financial Officer55
Gregoire de MontchalinChief Accounting & Reporting Officer-
Mr. Matthieu CaillatGroup Chief Technology & AI Officer, Chief Executive Officer of AXA Group Operations-
Ms. Anu VenkataramanGroup Chief Strategy Officer & Head of Investor Relations-
Ms. Ulrike DecoeneGroup Chief Communication, Brand & Sustainability Officer-
Ms. Karima SilventDeputy General Secretary, in charge of HR, Compliance, Audit, AXA EssentiALL & GIE AXA51
Mr. Hassan El-ShabrawishiChief Executive Officer of International Markets-
Mr. Guillaume BorieGlobal Head of Finance, Strategy, Underwriting, Risk & Technology39

Prüfungsrisiko

3

Vorstandsrisiko

2

Vergütungsrisiko

6

Aktionärsrechterisiko

6

Teil 2 · Der Preis und der Einstiegszeitpunkt

Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.

Latest News

Recent headlines for AXAHF, sourced from Markets Gazette.

No recent news for AXAHF.